EpiSKope

AI Powered Next Generation Viral Immunogenic Peptide Evaluation Resource

ABOUT EpiSKope

EpiSKope is a next-generation AI-powered viral immunogenic peptide evaluation resource for comprehensive prediction, evaluation and prioritization of B-cell and T-cell epitopes across human-infecting viruses. EpiSKope enables systematic identification and ranking of candidate epitopes from both curated viral proteins and user-submitted protein sequences, eliminating the need for multiple independent prediction tools. The platform integrates transformer-based protein language models, sequence-derived physicochemical analysis, hierarchical ensemble machine learning, biological safety assessment and interactive structural visualization into a single automated workflow.

โœฆ Key Screening Features โœฆ

๐Ÿงช
Antigenicity
ACC transformation
โ˜ฃ๏ธ
Toxicity
SVM dipeptide analysis
๐ŸŒฟ
Allergenicity
FAO/WHO criteria
โš ๏ธ
ADE Risk
Motif-based profiling
๐Ÿงฌ
3D-Structure Mapping
RCSB PDB coordinates
๐Ÿค–
ML Confidence
Stacking ensemble score
๐Ÿ’‰
Immunological Evidence
B-score + T-score
๐Ÿ›ก๏ธ
Safety Assessment
Unified penalty layer
Scalable
All viral species
Automated
End-to-end pipeline
Rigorous
Scientifically validated
0
Total Visits
0
Visits Today
1
This Session

DOCUMENTATION

Official Technical Specification Manual for the EpiSKope Universal AI-Based Viral Epitope Prediction Server.

1. Data Architecture & ETL Pipeline

To prevent machine learning models from overfitting to redundant or internal viral fragments, EpiSKope utilizes an automated Extraction, Transformation, and Loading (ETL) pipeline governed by strict mathematical logic.

Biological Exclusion Sieve & Deduplication

Genomic data queried from UniProt and NCBI contains massive redundancy. The pipeline utilizes a linguistic sieve to isolate surface-exposed structural antigens while discarding unviable targets (polymerases, helicases, internal replication factors). Additionally, the system employs an O(1) Memory Hashing Deduplication Shield to purge identical sub-strains before database commitment.

151,000+
Redundant sequences purged
4,688
Curated surface antigens
13,138
3D PDB coordinates indexed
999
Human-infecting species

2. Mathematical Pipeline & Feature Engineering

The core prediction engine abandons generic motif-matching in favor of mathematically optimized physicochemical profiling combined with deep Protein Language Models (PLMs).

Biological Safety Gating

Before a peptide is passed to the final ranking matrix, it is subjected to strict thresholding parameters to simulate clinical viability:

  • Antigenicity Gate: Evaluated via alignment-free Autocross-Covariance (ACC). Peptides <0.4 are rejected.
  • Toxicity Gate: Evaluated via SVM analyzing dipeptide composition matrices. Probabilities >0.5 are flagged as toxic.
  • Allergenicity Gate: Cross-referenced against FAO/WHO criteria (>35% identity over 80 aa).

The Unified Scoring Formulation

To provide a singular, actionable metric, EpiSKope calculates a Unified Score (\(U_{score}\)) harmonizing ML probability with biophysical propensities, penalized by clinical risks.

Equation 1 โ€” Unified Scoring Formula
$$ U_{score} = (\alpha \cdot P_{ML}) + \left(\beta \cdot \sum_{i=1}^{n} \text{Norm}(F_i)\right) - (\gamma \cdot P_{tox} + \delta \cdot P_{allergen}) $$

Deep Transformer Hidden-State Extraction

To capture global structural context, sequences are tokenized into high-dimensional tensors via two pre-trained PLMs. The multi-source feature space (\(X_i\)) is concatenated for the ML classifiers.

Equation 2 โ€” Multi-Source Feature Concatenation
$$ X_i = V_{\text{ESM-2}} \parallel V_{\text{ProtBERT}} \in \mathbb{R}^{2304} $$

3. Machine Learning Validation & Stacking Ensemble

The 2304-dimensional feature space is processed by a highly tuned Stacking Ensemble comprising 8 algorithms (XGBoost, LightGBM, CatBoost, Random Forest, Extra Trees, SVM-Linear, Logistic Regression, Deep MLP). To mathematically prove generalized predictive power, the architecture was evaluated using a strict 80/20 Stratified Holdout methodology on unseen validation sets.

Pipeline Target F1-Score Matthews Correlation (MCC) AUC-ROC
T-Cell Pipeline (Base Models) 0.4477 - 0.6304 0.1925 - 0.2956 โ€”
๐Ÿ† T-Cell Stacking Ensemble 0.5334 0.3122 0.7154
B-Cell Pipeline (Base Models) 0.4465 - 0.6266 0.2687 - 0.3877 โ€”
๐Ÿ† B-Cell Stacking Ensemble 0.5303 0.3644 0.7765

4. Intellectual Property

  • Claim 1: Unified Dual-Route Architecture enabling indexed relational tracking and zero-shot ML sequence analysis with dynamic NCBI fallback.
  • Claim 2: Multi-Source Transformer Pipeline fusing ESM-2 and ProtBERT dimensions into an 8-algorithm stacking ensemble.
  • Claim 3: Integrated Safety Sieve executing real-time gating for conservancy, toxicity, allergenicity, and ADE mitigation.

Meet the Team

Dr. Mukesh Chourasia
Dr. Mukesh Chourasia
Center for Computational Biology and Bioinformatics
Amity University Uttar Pradesh, Noida
Project Design and Analysis
โœ‰๏ธ mchourasia@amity.edu
Dr. Jitender Kumar
Dr. Jitender Kumar
Center for Computational Biology and Bioinformatics
Amity University Uttar Pradesh, Noida
Statistical Analysis and Processing
โœ‰๏ธ jkumar4@amity.edu
Shnaya Mehla
Shnaya Mehla
Center for Computational Biology and Bioinformatics
Amity University Uttar Pradesh, Noida
Computational Biologist and Developer
โœ‰๏ธ shnayamehla0411@gmail.com
Krati Vyas
Krati Vyas
Center for Computational Biology and Bioinformatics
Amity University Uttar Pradesh, Noida
Computational Biologist and Developer
โœ‰๏ธ krativyas3@gmail.com